【Major Events】
Beijing Auto (01958) plans to invest 2 billion yuan to subscribe for the subscribed shares issued by BAIC New Energy
Dongyin International Holdings (00668) received a premium of approximately 78.57% from Silver Bond for privatization and will resume trading on September 3
CStone Pharmaceuticals (02096) signed a cooperation agreement with Tajiri on the non-small cell lung cancer drug TGRX-326
Fosun Pharma Hanlin (02696): The clinical trial application for the biosimilar drug HLX17 of Palbociclib monoclonal antibody was approved by the National Medical Products Administration
Sino Biopharmaceutical (02005): Obtained the drug production registration approval for Nicardipine Tablets (5mg)
XPeng Motors-W (09868) delivered 14,036 smart electric vehicles in August, a year-on-year increase of 3%
【Share Repurchase and Cancellation】
Tencent Holdings (00700) spent HKD 1.003 billion on September 2 to repurchase 2.65 million shares
Alibaba Group-W (09988) spent approximately USD 59.9767 million on August 30 to repurchase 5.7592 million shares
WuXi AppTec (02269) spent HKD 59.8116 million on September 2 to repurchase 5.48 million shares
Hygeia Healthcare (06078) spent HKD 36.4281 million on September 2 to repurchase 1.9972 million shares
Liaoning Port (02880) controlling shareholder proposed the company to formulate the second share repurchase plan with a repurchase amount not exceeding 840 million yuan
For more details, please refer to Zhitong Finance website (www.zhitongcaijing.com)

00700

TCEHY

TCTZF

80700

The Hong Kong stock market announcement includes Beijing Automotive's plan to invest 2 billion yuan to subscribe for shares of Beiqi New Energy. Tencent Holdings repurchased 2.65 million shares on September 2, spending 1.003 billion Hong Kong dollars. Other repurchase cases include Alibaba, WuXi AppTec, and Hygeia Medical. Sisai Pharmaceutical Group obtained the production registration approval for Nicotinamide tablets, while XPeng's smart electric vehicle delivery volume in August increased by 3% year-on-year

- Beijing Auto (01958) plans to invest 2 billion RMB in subscribing to shares issued by BAIC New Energy; Dongfeng International Holdings (00668) receives a 78.57% premium offer from Yinbang for privatization on September 3. Sinopharm Group (02005) obtains the drug production registration approval for Nicardipine Tablets (5mg). Tencent Holdings (00700) repurchases 2.65 million shares for 1.003 billion HKD on September 2. Alibaba-W (09988) spends about 599.767 million USD repurchasing 5.7592 million shares on August 30.
- Beiqi New Energy, Dongfeng International Holdings, Sinopharm Group, Tencent Holdings, and Alibaba-W engage in significant financial activities including investments, privatization offers, drug production approvals, and share repurchases in September and August.
- Sinopharm Group's approval for Nicardipine Tablets production and Tencent Holdings' share repurchase are notable events in the finance sector, reflecting strategic financial decisions by these companies.

Hong Kong Stock Announcement | Tencent Holdings spent over HKD 12 billion on share buybacks after performance